Harrow Health (HROW) Stock Forecast, Price Target & Predictions
HROW Stock Forecast
Harrow Health stock forecast is as follows: an average price target of $57.67 (represents a 64.40% upside from HROW’s last price of $35.08) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.
HROW Price Target
The average price target for Harrow Health (HROW) is $57.67 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $73.00 to $45.00. This represents a potential 64.40% upside from HROW's last price of $35.08.
HROW Analyst Ratings
According to 5 Wall Street analysts, Harrow Health's rating consensus is 'Buy'. The analyst rating breakdown for HROW stock is 0 'Strong Buy' (0.00%), 5 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Harrow Health Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 18, 2024 | Sahil Kazmi | B.Riley Financial | $73.00 | $56.41 | 29.41% | 108.10% |
| Oct 04, 2024 | Brooks O'Neil | Lake Street | $55.00 | $49.75 | 10.55% | 56.78% |
| Aug 09, 2024 | Chase Knickerbocker | Craig-Hallum | $45.00 | $35.25 | 27.66% | 28.28% |
| Jun 21, 2024 | Chase Knickerbocker | Craig-Hallum | $30.00 | $19.93 | 50.53% | -14.48% |
| Jun 03, 2024 | Brooks O'Neil | Loop Capital Markets | $25.00 | $17.68 | 41.44% | -28.73% |
| Jun 03, 2024 | Brooks O'Neil | Lake Street | $25.00 | $18.13 | 37.93% | -28.73% |
The latest Harrow Health stock forecast, released on Oct 18, 2024 by Sahil Kazmi from B.Riley Financial, set a price target of $73.00, which represents a 29.41% increase from the stock price at the time of the forecast ($56.41), and a 108.10% increase from HROW last price ($35.08).
Harrow Health Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 6 |
| Avg Price Target | - | $64.00 | $42.17 |
| Last Closing Price | $35.08 | $35.08 | $35.08 |
| Upside/Downside | -100.00% | 82.44% | 20.21% |
In the current month, the average price target of Harrow Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Harrow Health's last price of $35.08. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 04, 2024 | J.P. Morgan | Buy | Buy | Hold |
| Oct 04, 2024 | Craig-Hallum | Buy | Buy | Hold |
| Oct 04, 2024 | Lake Street | Buy | Buy | Hold |
| Aug 29, 2024 | Lake Street | Buy | Buy | Hold |
| Aug 09, 2024 | Craig-Hallum | Buy | Buy | Hold |
| Aug 09, 2024 | B. Riley | Buy | Buy | Hold |
| Jun 21, 2024 | Craig-Hallum | Buy | Buy | Hold |
| Jun 03, 2024 | Lake Street | Buy | Buy | Hold |
| May 15, 2024 | Craig-Hallum | Buy | Buy | Hold |
| May 15, 2024 | B. Riley | Buy | Buy | Hold |
| May 20, 2022 | B. Riley Securities | Buy | Buy | Hold |
Harrow Health's last stock rating was published by J.P. Morgan on Oct 04, 2024. The company gave HROW a "Buy" rating, the same as its previous rate.
Harrow Health Financial Forecast
Harrow Health Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $36.35M | $34.27M | $33.47M | $26.10M | $20.33M | $22.82M | $23.32M | $22.12M | $20.19M | $18.71M | $18.13M | $15.44M | $14.60M | $14.40M | $8.06M | $11.82M | $12.60M | $12.76M |
| Avg Forecast | $107.07M | $95.01M | $90.49M | $82.24M | $80.92M | $72.90M | $69.84M | $61.54M | $59.09M | $52.80M | $42.51M | $36.32M | $37.86M | $37.58M | $31.04M | $25.13M | $21.40M | $23.14M | $22.07M | $19.48M | $19.35M | $17.44M | $15.71M | $14.01M | $14.45M | $9.34M | $5.70M | $11.77M | $13.66M | $12.85M |
| High Forecast | $111.05M | $98.54M | $93.85M | $85.30M | $83.93M | $75.61M | $72.44M | $63.82M | $61.28M | $53.13M | $44.09M | $36.79M | $39.26M | $37.64M | $32.19M | $26.06M | $22.20M | $23.14M | $22.07M | $19.48M | $19.35M | $17.44M | $15.71M | $14.01M | $14.45M | $9.34M | $5.70M | $11.77M | $13.66M | $12.85M |
| Low Forecast | $104.77M | $92.97M | $88.55M | $80.47M | $79.18M | $71.33M | $68.34M | $60.22M | $57.82M | $52.48M | $41.60M | $35.84M | $37.04M | $37.53M | $30.37M | $24.59M | $20.94M | $23.14M | $22.07M | $19.48M | $19.35M | $17.44M | $15.71M | $14.01M | $14.45M | $9.34M | $5.70M | $11.77M | $13.66M | $12.85M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 9 | 8 | 6 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 0.91% | 1.08% | 1.04% | 0.95% | 0.99% | 1.06% | 1.14% | 1.04% | 1.07% | 1.15% | 1.10% | 1.01% | 1.54% | 1.41% | 1.00% | 0.92% | 0.99% |
Harrow Health's average Quarter revenue forecast for Mar 24 based on 1 analysts is $36.32M, with a low forecast of $35.84M, and a high forecast of $36.79M. HROW's average Quarter revenue forecast represents a -0.10% decrease compared to the company's last Quarter revenue of $36.35M (Dec 23).
Harrow Health EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 9 | 8 | 6 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-1.61M | $1.74M | $2.35M | $1.21M | $-1.78M | $-2.78M | $5.00K | $162.00K | $11.25M | $-3.86M | $3.78M | $-585.00K | $3.63M | $1.26M | $-3.44M | $-851.00K | $-1.43M | $9.79M |
| Avg Forecast | $-39.91K | $-35.42K | $-33.73K | $-30.66K | $-30.17K | $-27.18K | $-26.04K | $-22.94K | $-22.03K | $-19.68K | $-15.85K | $-13.54K | $-14.11K | $-14.01K | $-11.57K | $-9.37K | $-7.98K | $995.13K | $949.16K | $277.69K | $831.96K | $749.73K | $675.42K | $1.76M | $621.19K | $401.51K | $245.11K | $-12.85M | $587.50K | $552.69K |
| High Forecast | $-39.06K | $-34.66K | $-33.01K | $-30.00K | $-29.52K | $-26.59K | $-25.48K | $-22.45K | $-21.55K | $-19.56K | $-15.51K | $-13.36K | $-13.81K | $-13.99K | $-11.32K | $-9.17K | $-7.81K | $995.13K | $949.16K | $333.23K | $831.96K | $749.73K | $675.42K | $2.11M | $621.19K | $401.51K | $245.11K | $-10.28M | $587.50K | $552.69K |
| Low Forecast | $-41.40K | $-36.73K | $-34.99K | $-31.80K | $-31.29K | $-28.19K | $-27.00K | $-23.79K | $-22.84K | $-19.80K | $-16.44K | $-13.72K | $-14.64K | $-14.03K | $-12.00K | $-9.72K | $-8.27K | $995.13K | $949.16K | $222.15K | $831.96K | $749.73K | $675.42K | $1.41M | $621.19K | $401.51K | $245.11K | $-15.42M | $587.50K | $552.69K |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 114.23% | -124.48% | -203.25% | -129.16% | 222.86% | -2.79% | 0.01% | 0.58% | 13.53% | -5.15% | 5.59% | -0.33% | 5.84% | 3.13% | -14.02% | 0.07% | -2.43% | 17.71% |
2 analysts predict HROW's average Quarter EBITDA for Dec 23 to be $-14.11K, with a high of $-13.81K and a low of $-14.64K. This is -100.81% lower than Harrow Health's previous annual EBITDA (Sep 23) of $1.74M.
Harrow Health Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 9 | 8 | 6 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-9.15M | $-4.39M | $-4.23M | $-6.64M | $1.05M | $-6.46M | $-6.24M | $-2.30M | $-7.42M | $-8.33M | $-6.82M | $217.00K | $1.15M | $8.64M | $-237.00K | $-12.91M | $7.41M | $-11.47M |
| Avg Forecast | $21.42M | $12.14M | $10.71M | $9.64M | $9.40M | $5.36M | $5.12M | $2.62M | $803.30K | $-1.87M | $-6.55M | $-7.77M | $-1.55M | $1.31M | $-1.43M | $-1.90M | $-4.17M | $-178.09K | $-712.38K | $-2.25M | $-1.51M | $-623.33K | $1.19M | $439.43K | $178.09K | $-3.38M | $-6.06M | $-14.20M | $178.09K | $-1.25M |
| High Forecast | $22.46M | $12.72M | $11.23M | $10.11M | $9.86M | $5.61M | $5.36M | $2.74M | $842.09K | $-1.82M | $-6.36M | $-7.55M | $-1.50M | $1.37M | $-1.39M | $-1.85M | $-4.05M | $-178.09K | $-712.38K | $-1.80M | $-1.51M | $-623.33K | $1.19M | $527.31K | $178.09K | $-3.38M | $-6.06M | $-11.36M | $178.09K | $-1.25M |
| Low Forecast | $20.82M | $11.80M | $10.41M | $9.37M | $9.14M | $5.21M | $4.97M | $2.55M | $780.87K | $-1.96M | $-6.86M | $-8.14M | $-1.62M | $1.27M | $-1.50M | $-2.00M | $-4.37M | $-178.09K | $-712.38K | $-2.70M | $-1.51M | $-623.33K | $1.19M | $351.54K | $178.09K | $-3.38M | $-6.06M | $-17.04M | $178.09K | $-1.25M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 5.91% | -3.35% | 2.96% | 3.49% | -0.25% | 36.30% | 8.76% | 1.02% | 4.90% | 13.36% | -5.74% | 0.49% | 6.45% | -2.55% | 0.04% | 0.91% | 41.61% | 9.20% |
Harrow Health's average Quarter net income forecast for Mar 23 is $-1.90M, with a range of $-2.00M to $-1.85M. HROW's average Quarter net income forecast represents a -280.48% decrease compared to the company's last Quarter net income of $1.05M (Dec 22).
Harrow Health SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 9 | 8 | 6 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $26.21M | $21.03M | $19.96M | $15.89M | $15.24M | $15.42M | $14.19M | $13.40M | $12.67M | $11.36M | $9.12M | $8.16M | $7.44M | $8.44M | $6.95M | $8.42M | $7.70M | $8.61M |
| Avg Forecast | $67.49M | $59.89M | $57.04M | $51.84M | $51.01M | $45.95M | $44.03M | $38.79M | $37.25M | $33.29M | $26.80M | $22.89M | $23.86M | $23.69M | $19.57M | $15.84M | $13.49M | $14.59M | $13.92M | $12.36M | $12.20M | $10.99M | $9.90M | $8.83M | $9.11M | $5.89M | $3.59M | $9.26M | $8.61M | $8.10M |
| High Forecast | $70.00M | $62.12M | $59.16M | $53.77M | $52.90M | $47.66M | $45.66M | $40.23M | $38.63M | $33.49M | $27.79M | $23.19M | $24.75M | $23.73M | $20.29M | $16.43M | $13.99M | $14.59M | $13.92M | $14.83M | $12.20M | $10.99M | $9.90M | $8.83M | $9.11M | $5.89M | $3.59M | $11.11M | $8.61M | $8.10M |
| Low Forecast | $66.04M | $58.61M | $55.82M | $50.73M | $49.91M | $44.97M | $43.08M | $37.96M | $36.45M | $33.08M | $26.22M | $22.59M | $23.35M | $23.66M | $19.15M | $15.50M | $13.20M | $14.59M | $13.92M | $9.89M | $12.20M | $10.99M | $9.90M | $8.83M | $9.11M | $5.89M | $3.59M | $7.41M | $8.61M | $8.10M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.10% | 0.89% | 1.02% | 1.00% | 1.13% | 1.06% | 1.02% | 1.08% | 1.04% | 1.03% | 0.92% | 0.92% | 0.82% | 1.43% | 1.94% | 0.91% | 0.89% | 1.06% |
Harrow Health's average Quarter SG&A projection for Mar 24 is $22.89M, based on 1 Wall Street analysts, with a range of $22.59M to $23.19M. The forecast indicates a -12.66% fall compared to HROW last annual SG&A of $26.21M (Dec 23).
Harrow Health EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 7 | 9 | 8 | 6 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.26 | $-0.13 | $-0.14 | $-0.22 | $0.04 | $-0.24 | $-0.23 | $-0.08 | $-0.27 | $-0.39 | $-0.26 | $0.08 | $0.04 | $0.66 | $0.16 | $-0.92 | $0.29 | $-1.26 |
| Avg Forecast | $0.60 | $0.34 | $0.30 | $0.27 | $0.26 | $0.15 | $0.14 | $0.07 | $0.02 | $-0.05 | $-0.18 | $-0.22 | $-0.04 | $0.04 | $-0.04 | $-0.05 | $-0.12 | $-0.01 | $-0.02 | $-0.04 | $-0.04 | $-0.02 | $0.03 | $0.01 | $0.01 | $-0.10 | $-0.17 | $-0.02 | $0.01 | $-0.04 |
| High Forecast | $0.63 | $0.36 | $0.31 | $0.28 | $0.28 | $0.16 | $0.15 | $0.08 | $0.02 | $-0.05 | $-0.18 | $-0.21 | $-0.04 | $0.04 | $-0.04 | $-0.05 | $-0.11 | $-0.01 | $-0.02 | $-0.04 | $-0.04 | $-0.02 | $0.03 | $0.01 | $0.01 | $-0.10 | $-0.17 | $-0.02 | $0.01 | $-0.04 |
| Low Forecast | $0.58 | $0.33 | $0.29 | $0.26 | $0.26 | $0.15 | $0.14 | $0.07 | $0.02 | $-0.06 | $-0.19 | $-0.23 | $-0.05 | $0.04 | $-0.04 | $-0.06 | $-0.12 | $-0.01 | $-0.02 | $-0.04 | $-0.04 | $-0.02 | $0.03 | $0.01 | $0.01 | $-0.10 | $-0.17 | $-0.02 | $0.01 | $-0.04 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 6.00% | -3.55% | 3.50% | 4.13% | -0.34% | 48.00% | 11.50% | 2.41% | 6.35% | 22.29% | -7.80% | 5.59% | 8.00% | -6.95% | -0.94% | 46.00% | 58.00% | 36.00% |
According to 1 Wall Street analysts, Harrow Health's projected average Quarter EPS for Mar 23 is $-0.05, with a low estimate of $-0.06 and a high estimate of $-0.05. This represents a -233.33% decrease compared to HROW previous annual EPS of $0.04 (Dec 22).